- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 55.91M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $48.89M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $52.89M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $29.16M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $49.07M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $43.9M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $64.42M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $74.71M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $107.28M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $77.71M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $110.54M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 53.52M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $5.94M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $96.25M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $106.89M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.24 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.24 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.92M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $17.33M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$12.67M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$13.98M |
| Revenue | Q1 2025 · Mar 31, 2024 | $140K |